C.Q. Pharmaceutical Holding Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
C.Q. Pharmaceutical Holding Co., Ltd. carries a market capitalization of 9.31B, placing it among publicly traded companies globally. Its enterprise value stands at 31.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.31B |
| Enterprise Value | 31.37B |
Share Statistics
C.Q. Pharmaceutical Holding Co., Ltd. currently has 1.73B shares outstanding.
| Shares Outstanding | 1.73B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
C.Q. Pharmaceutical Holding Co., Ltd. trades at a trailing price-to-earnings ratio of 27.29. The price-to-sales ratio is 0.11, and the price-to-book ratio stands at 0.99.
| PE Ratio | 27.29 |
| PS Ratio | 0.11 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | 30.37 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, C.Q. Pharmaceutical Holding Co., Ltd. trades at an EV/EBITDA multiple of 16.20 and an EV/FCF ratio of 30.23. The EV/Sales ratio of 0.38 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.20 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.38 |
| EV / EBITDA | 16.20 |
| EV / EBIT | 16.20 |
| EV / FCF | 30.23 |
Financial Position
C.Q. Pharmaceutical Holding Co., Ltd. maintains a current ratio of 1.27, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 142.95, indicating elevated leverage, while an interest coverage ratio of 2.02 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.27 |
| Quick Ratio | 0.14 |
| Debt / Equity | 142.95 |
| Debt / EBITDA | 12.23 |
| Interest Coverage | 2.02 |
Financial Efficiency
C.Q. Pharmaceutical Holding Co., Ltd. posts a return on equity of 3.67 and a return on invested capital of 3.99.
| Return on Equity (ROE) | 3.67 |
| Return on Assets (ROA) | 0.49 |
| Return on Invested Capital (ROIC) | 3.99 |
| Return on Capital Employed (ROCE) | 2.61 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.87 |
Taxes
Over the trailing twelve months, C.Q. Pharmaceutical Holding Co., Ltd. has paid 130.59M in income taxes, reflecting an effective tax rate of 22.57.
| Income Tax | 130.59M |
| Effective Tax Rate | 22.57 |
Stock Price Statistics
C.Q. Pharmaceutical Holding Co., Ltd.'s stock has gained approximately 6.31164% over the past 52 weeks. The 50-day moving average sits at 5.71, while the 200-day moving average is 5.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6.31164% |
| 50-Day Moving Average | 5.71 |
| 200-Day Moving Average | 5.76 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, C.Q. Pharmaceutical Holding Co., Ltd. generated 81.97B in revenue and converted that into 327.17M in net income, yielding earnings per share of 0.25. EBITDA reached 1.94B, while operating income came in at 1.94B.
| Revenue | 81.97B |
| Gross Profit | 5.91B |
| Operating Income | 1.94B |
| Pretax Income | 578.66M |
| Net Income | 327.17M |
| EBITDA | 1.94B |
| EBIT | 1.94B |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
C.Q. Pharmaceutical Holding Co., Ltd. holds 6.29B in cash and equivalents against 23.69B in total debt, resulting in a net debt position of 15.17B. Total book value stands at 9.00B, with working capital of 12.31B providing operational flexibility.
| Cash & Cash Equivalents | 6.29B |
| Total Debt | 23.69B |
| Net Debt | 15.17B |
| Equity (Book Value) | 9.00B |
| Book Value Per Share | 5.03 |
| Working Capital | 12.31B |
Cash Flow
After subtracting -293.96M in capital expenditures, free cash flow totaled -293.96M - equivalent to -0.16 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -293.96M |
| Free Cash Flow | -293.96M |
| FCF Per Share | -0.16 |
Margins
C.Q. Pharmaceutical Holding Co., Ltd. operates with a gross margin of 7.21, reflecting its pricing power and cost economics. The operating margin of 2.36 and net profit margin of 0.40 provide insight into operational efficiency.
| Gross Margin | 7.21 |
| Operating Margin | 2.36 |
| Pretax Margin | 0.71 |
| Profit Margin | 0.40 |
| EBITDA Margin | 2.36 |
Dividends & Yields
The company's payout ratio of 180.05 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.57 |
| Dividend Yield | N/A |
| Payout Ratio | 180.05 |
| Shareholder Yield | 21.95 |
| FCF Yield | 3.29 |
Stock Splits
C.Q. Pharmaceutical Holding Co., Ltd.'s most recent stock split took place on April 16, 2010 with a 2:3 split ratio.
| Last Split Date | 4/16/2010 |
| Split Ratio | 2:3 |
Scores
C.Q. Pharmaceutical Holding Co., Ltd. posts an Altman Z-Score of 1.82, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.82 |